RVP vs. MGRM, STIM, NSPR, ICCM, HSAQ, WOK, CTSO, APYX, DHAI, and NVNO
Should you be buying Retractable Technologies stock or one of its competitors? The main competitors of Retractable Technologies include Monogram Orthopaedics (MGRM), Neuronetics (STIM), InspireMD (NSPR), IceCure Medical (ICCM), Health Sciences Acquisitions Co. 2 (HSAQ), WORK Medical Technology Group LTD Ordinary Shares (WOK), Cytosorbents (CTSO), Apyx Medical (APYX), DIH Holding US (DHAI), and enVVeno Medical (NVNO). These companies are all part of the "surgical & medical instruments" industry.
Retractable Technologies vs.
Monogram Orthopaedics (NASDAQ:MGRM) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.
In the previous week, Retractable Technologies had 2 more articles in the media than Monogram Orthopaedics. MarketBeat recorded 2 mentions for Retractable Technologies and 0 mentions for Monogram Orthopaedics. Retractable Technologies' average media sentiment score of 0.50 beat Monogram Orthopaedics' score of 0.00 indicating that Retractable Technologies is being referred to more favorably in the news media.
0.5% of Monogram Orthopaedics shares are owned by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are owned by institutional investors. 28.1% of Monogram Orthopaedics shares are owned by company insiders. Comparatively, 54.6% of Retractable Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Retractable Technologies has higher revenue and earnings than Monogram Orthopaedics. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.
Monogram Orthopaedics has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Retractable Technologies' return on equity of -17.15% beat Monogram Orthopaedics' return on equity.
Monogram Orthopaedics has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 1.94, indicating that its share price is 94% more volatile than the S&P 500.
Monogram Orthopaedics presently has a consensus price target of $4.00, suggesting a potential upside of 49.25%. Given Monogram Orthopaedics' stronger consensus rating and higher possible upside, equities analysts plainly believe Monogram Orthopaedics is more favorable than Retractable Technologies.
Monogram Orthopaedics received 2 more outperform votes than Retractable Technologies when rated by MarketBeat users. Likewise, 100.00% of users gave Monogram Orthopaedics an outperform vote while only 0.00% of users gave Retractable Technologies an outperform vote.
Summary
Monogram Orthopaedics and Retractable Technologies tied by winning 9 of the 18 factors compared between the two stocks.
Get Retractable Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for RVP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Retractable Technologies Competitors List
Related Companies and Tools
This page (NYSE:RVP) was last updated on 1/22/2025 by MarketBeat.com Staff
Free RVP Stock Alerts